| Net loss | -7.48M |
| Depreciation and amortization | 94.94K |
| Stock-based compensation | 246.5K |
| Provision for losses on accounts receivable | |
| Provision for inventory obsolescence | |
| Accounts receivable | 3.14M |
| Inventories | 114K |
| Prepayments and other current assets | |
| Other assets | 27.86K |
| Accounts payable | 13.46K |
| Accrued expenses and other liabilities | -169.91K |
| Total adjustments | 7.37M |
| Net cash provided by (used in) operating activities | -107.31K |
| Acquisition of property and equipment | -3.85K |
| Net cash used in investing activities | -3.85K |
| Net proceeds (repayments) of bank financings | 398.64K |
| Net cash provided by (used in) financing activities | -1.64M |
| Cumulative translation adjustment | -58.4K |
| Net increase in cash and cash equivalents | -1.81M |
| Cash and cash equivalents at beginning of year | 1.88M |
| Cash and cash equivalents at end of period | 70.32K |
| Interest | 297.28K |
| Income tax | 45.95K |